Tuberculosis (TB) remains a leading cause of illness and death in Asia and the Pacific. The overlapping pandemics of TB and HIV create major challenges in under-resourced settings. Our broad TB research program ranges from improving understanding of physiological responses to TB infection, to helping TB programs implement treatment guidelines more effectively. We are using supplemental nutrition treatments to improve outcomes in people with TB. Proposed studies include investigating ways to expand TB screening and preventive therapy in people exposed to the infection, and to optimise the integration of TB and HIV care for people with both infections.

Staff: Anna Ralph, Nick Anstey